Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. - Wikidata - wikimedia - TriplyDB

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

http://www.wikidata.org/entity/Q33372850

about

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis Structural basis for complement factor I control and its disease-associated sequence polymorphisms Eculizumab for dense deposit disease and C3 glomerulonephritis Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN Overview of C3 Glomerulopathy Current Understanding of the Role of Complement in IgA Nephropathy Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature Nanosized contrast agents to noninvasively detect kidney inflammation by magnetic resonance imaging Update on membranoproliferative GN Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion Complement regulator CD46: genetic variants and disease associations Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.Inhibiting complement activation on cells at the step of C3 cleavage.Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis.Anti-glomerular basement membrane glomerulonephritis and thrombotic microangiopathy in first degree relatives: a case report.Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases.C3 mesangial proliferative glomerulonephritis initially presenting with atypical hemolytic uremic syndrome: a case report Different types of glomerulonephritis associated with the dysregulation of the complement alternative pathway in 2 brothers: A case report.Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.Defective complement inhibitory function predisposes to renal disease.Recurrence of complement factor H-related protein 5 nephropathy in a renal transplant Current concepts in C3 glomerulopathy.Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.Regulating complement in the kidney: insights from CFHR5 nephropathy.Complement involvement in kidney diseases: From physiopathology to therapeutical targeting A rare penetrant mutation in CFH confers high risk of age-related macular degeneration.Association of a novel complement factor H mutation with severe crescentic and necrotizing glomerulonephritis.Eculizumab and recurrent C3 glomerulonephritis Secondary focal and segmental glomerulosclerosis associated with single-nucleotide polymorphisms in the genes encoding complement factor H and C3.C3 glomerulonephritis associated with monoclonal gammopathy: a case series.Treatment options for C3 glomerulopathy Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus.Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?The role of molecular genetics in diagnosing familial hematuria(s).

P2860

Q24615589-772AC568-AE9F-44A8-9F66-A8FF08366EFC Q24622871-0DF6CCC6-5FE3-4921-AEE9-92C316DBCA41 Q24632330-61267008-5009-4BC8-8CA1-02E085351AFA Q24650823-0D0744F5-FF3C-4422-B4E8-EE0A1728BEDE Q24651118-D6F8820C-73BA-426B-AAD1-BCCB41C12038 Q26741542-4D10AA51-84B1-4F1A-B9B2-D9C70BA6FB59 Q26747262-323E81C8-DBC1-46B8-945E-8E81906E3E78 Q26852163-882B21E1-5DE4-4153-912B-07A926D44156 Q26864297-DF67F5E1-1529-45E0-B622-2217F1306D9C Q26864381-EEF86D6F-20A7-40D6-9415-C702C0DFCCE3 Q26866127-BFDD5418-E4A1-4761-995E-390DB7DFF72F Q27008508-7C2D63AC-7913-4C0D-8CAF-2BCE9B03703E Q28263110-A3CBA6E3-1EA6-4872-A4AD-4CA4F5B24273 Q30415634-F2AF70CF-FA66-4ECC-8E52-B5A63792E45A Q33378236-CDFEF638-390F-44AC-AE55-2FB50D44BB22 Q33384196-591D68A7-1FB2-4E3D-BF4D-C265159939B0 Q33396467-2B4AD79E-05A1-4300-A198-352F8E307927 Q33402542-1960A374-1271-411E-8B5F-85CD1852C55F Q33425891-0D6F7BA6-AB6C-4412-B449-82121E138A53 Q33425911-F17599B6-44B2-4EA8-A791-524E6E35E793 Q33434161-4E5103CC-F7AE-47D8-8742-4A2ED38A7A53 Q33818095-CDDBDBB7-FBC0-46E6-83A3-6E05A1209274 Q33849695-BD7385F7-7B2D-4D93-9EA5-BDF17B8C654B Q34295006-E17DDA49-7218-485E-965E-8F732CDEF504 Q34465747-957940AB-FF49-4BA2-B95C-F3FDA919D423 Q34467879-A32472B8-8772-48FC-AC44-C0957CF54885 Q34574482-A6B4E0F5-263E-4FC6-8F8B-58F50B08C867 Q35030648-7D74F1DF-35A2-4D41-8CAB-FD0F1AE38097 Q35246525-DC9EB09D-27FC-41C6-98CE-843480F780F3 Q35532337-EE9705B5-11A7-4B71-8C82-E08BFCBBEE63 Q35567841-CA35768C-D403-48CC-B2CD-7BDF94F2BAAF Q35577472-57C03DB4-D1DE-4DF9-A500-82B5F0EE2638 Q35597061-6BC3A82D-ED8A-4D1C-8B6B-8F8138FE4AFC Q35597310-0F98ACF5-0586-42D6-AE29-63942CA7F85E Q35611793-790CEF0D-BCD8-4BE2-9C57-FC8D97D251DB Q35618793-51D9853C-5FB6-4B7C-A895-A5005A5457FF Q35624672-530C4168-B799-49A1-A2ED-FD0F8C8A5113 Q35907818-A090AE04-9CB9-4342-842D-87CB3CDACCBD Q35983428-F7E9B9DC-85B0-4157-AB83-4E8B3CBBEB3A Q36056811-518CFAEC-F2CE-4C60-A9AE-8BB492D5833B

P2860

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

http://www.wikidata.org/entity/Q33372850

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Primary glomerulonephritis wit ...... h haemolytic uraemic syndrome.

@ast

Primary glomerulonephritis wit ...... h haemolytic uraemic syndrome.

@en

type

label

Primary glomerulonephritis wit ...... h haemolytic uraemic syndrome.

@ast

Primary glomerulonephritis wit ...... h haemolytic uraemic syndrome.

@en

prefLabel

Primary glomerulonephritis wit ...... h haemolytic uraemic syndrome.

@ast

Primary glomerulonephritis wit ...... h haemolytic uraemic syndrome.

@en

P1433

Q33372850-C3EECDF9-66D1-41C5-A57D-377BF47B9DBD

P1476

Q33372850-D26F43FE-8AB2-4B46-AAF2-88E57F33DB0A

P2093

Q33372850-4589B2D5-10D7-4BE4-9E21-A334A73B9D95

Q33372850-5C305DBC-4089-41C0-B3A2-39BEE1EA7DF3

Q33372850-7415470A-DB5E-4600-AE5E-763B886005E5

Q33372850-7D0F86B7-901C-41A4-84CA-81EA388BCEFA

Q33372850-9DAEF97B-8212-40EE-9B59-9DEEFB3C1FC3

Q33372850-B26CB877-6C42-4700-B3E3-5CC321CF8E55

Q33372850-C5C8B011-FC83-44FE-8298-08791B02B2B8

Q33372850-CCD41ADE-F68B-4BD3-9F84-D14C29B5634F

Q33372850-FD49DA9C-384D-40D7-805B-F52193501C6D

P2860

Q33372850-055FE38E-50FD-443C-AF78-E4094CCA722E

Q33372850-070C1DE7-795A-4F7B-BA99-C859B372772F

Q33372850-075E19B9-30CA-4080-9C78-30A83A4425DC

Q33372850-253476EE-77FB-4EC6-BBC4-6A931CECA1D1

Q33372850-28AA2C32-6825-4C71-9B3D-ECE3EE25E799

Q33372850-2E076AE7-234E-4A7E-9BAC-20E9EDCAE573

Q33372850-3D6C272E-6C53-4A95-A5D0-1CCD7EE0915D

Q33372850-741D7C8A-AD78-4539-B37B-3DC7A02151E1

Q33372850-7565CD07-B849-414C-A2BD-BE5E6C319764

Q33372850-7AC2D098-8A1D-4A39-91D5-2CB71FDEB52C

P304

Q33372850-2A2FD13E-975B-417E-B8AB-44D2142018D7

P31

Q33372850-88A2F71F-C333-4764-96BC-6482BCE139BC

P356

Q33372850-310874F6-DE6B-487F-B0F3-F3E1316CA505

P407

Q33372850-4A6948F3-1FD2-41A1-A898-90F85A5469FE

P433

Q33372850-746F2978-0227-47D4-A588-38F3C20C334C

P478

Q33372850-803DFA8E-CAB6-469C-B0F5-8462BAF93F90

P50

Q33372850-A011E0B3-F8CC-4872-A833-B0F484EC18CC

Q33372850-D2E35204-41E9-4EB1-A0DE-DFB206FC870C

P577

Q33372850-F9CE41F8-96C0-4382-8379-C4C154EDC89D

P5875

Q33372850-432EC6EE-8F35-4A99-A2F2-22985FA8CF24

P698

Q33372850-ADEB16AC-762B-4450-8732-7E68DDB79E1A

P921

Q33372850-062F3F5F-1B3B-466C-BEC7-D48D371AD562

P932

Q33372850-1FF17525-E607-4410-B4A1-100AD46EAC49

P356

JMG.2006.045328

P1433

Journal of Medical Genetics

P1476

Primary glomerulonephritis wit ...... h haemolytic uraemic syndrome.

@en

P2093

Bertrand Knebelmann

http://www.w3.org/2001/XMLSchema#string

Fadi Fakhouri

http://www.w3.org/2001/XMLSchema#string

Jacques Blouin

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Grünfeld

http://www.w3.org/2001/XMLSchema#string

Laure-Hélène Noël

http://www.w3.org/2001/XMLSchema#string

Moglie Lequintrec

http://www.w3.org/2001/XMLSchema#string

Philippe Lesavre

http://www.w3.org/2001/XMLSchema#string

Rémi Salomon

http://www.w3.org/2001/XMLSchema#string

Véronique Frémeaux-Bacchi

http://www.w3.org/2001/XMLSchema#string

P2860

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.

Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.

Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.

Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries

Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.

Familial haemolytic uraemic syndrome and an MCP mutation.

Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases.

Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

P304

193-199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JMG.2006.045328

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

Véronique Frémeaux-Bacchi

P577

2006-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6775642

http://www.w3.org/2001/XMLSchema#string

P698

17018561

http://www.w3.org/2001/XMLSchema#string

P921

glomerulonephritis

P932

2598029

http://www.w3.org/2001/XMLSchema#string